Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Modern Trends in Pharmacopsychiatry
|
September 17, 2014
Inflammation, neurotoxins and psychiatric disorders
Aye-Mu Myint
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 31, 2013
Immuno-neuroendocrino-neurochemical interaction in psychiatric disorders
Aye Mu Myint
Frontiers in Psychiatry
|
July 15, 2022
Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders
Aye-Mu Myint, Angelos Halaris
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 5, 2013
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis
Aye-Mu Myint, Yong-Ku Kim
Journal of Affective Disorders
|
August 13, 2004
Clinical application of low serum cholesterol as an indicator for suicide risk in major depression
Yong-Ku Kim, Aye-Mu Myint
Frontiers in Psychiatry
|
January 2, 2025
Editorial: Methods and applications in molecular psychiatry: 2023
Sehyoun Yoon, Aye-Mu Myint, Karl Bechter
Journal of Psychopharmacology (Oxford, England)
|
April 5, 2012
The metabolic syndrome in schizophrenia: is inflammation a contributing cause?
Brian E Leonard, Markus Schwarz, Aye Mu Myint
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 6, 2011
The role of the kynurenine metabolism in major depression
Aye-Mu Myint, Markus J Schwarz, Norbert Müller
Current Pharmaceutical Design
|
March 3, 2011
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects
Norbert Müller, Aye-Mu Myint, Markus J Schwarz
Dialogues in Clinical Neuroscience
|
November 3, 2009
The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment
Norbert Müller, Aye-Mu Myint, Markus J Schwarz
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Modern Trends in Pharmacopsychiatry
|
September 17, 2014
Inflammation, neurotoxins and psychiatric disorders
Aye-Mu Myint
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 31, 2013
Immuno-neuroendocrino-neurochemical interaction in psychiatric disorders
Aye Mu Myint
Frontiers in Psychiatry
|
July 15, 2022
Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders
Aye-Mu Myint, Angelos Halaris
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 5, 2013
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis
Aye-Mu Myint, Yong-Ku Kim
Journal of Affective Disorders
|
August 13, 2004
Clinical application of low serum cholesterol as an indicator for suicide risk in major depression
Yong-Ku Kim, Aye-Mu Myint
Frontiers in Psychiatry
|
January 2, 2025
Editorial: Methods and applications in molecular psychiatry: 2023
Sehyoun Yoon, Aye-Mu Myint, Karl Bechter
Journal of Psychopharmacology (Oxford, England)
|
April 5, 2012
The metabolic syndrome in schizophrenia: is inflammation a contributing cause?
Brian E Leonard, Markus Schwarz, Aye Mu Myint
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 6, 2011
The role of the kynurenine metabolism in major depression
Aye-Mu Myint, Markus J Schwarz, Norbert Müller
Current Pharmaceutical Design
|
March 3, 2011
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects
Norbert Müller, Aye-Mu Myint, Markus J Schwarz
Dialogues in Clinical Neuroscience
|
November 3, 2009
The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment
Norbert Müller, Aye-Mu Myint, Markus J Schwarz
Page
of 6